Rahul Pratap Singh

Dr. Rahul Pratap Singh

Amity Institute of Pharmacy, Amity University, Noida, India
orcid
Associate Professor in Pharmaceutics

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 August 2015 in Cogent Engineering
Verified
Journal Article
Open access
PAParatibha Aggarwal
Paratibha Aggarwal
Rahul Pratap SinghRahul Pratap Singh
Rahul Pratap Singh
YAYogesh Aggarwal
Yogesh Aggarwal
The research nowadays is mainly focusing on the basic science of cementitious material at nano/atomic level. Further, researchers are continuing to improve the durability and sustainability of concrete and have realized significant increment in mechanical properties of cementitious materials by incorporating nano-silica. The review paper summarizes the effect of nano-silica addition on mechanical, durability and microstructure characteristics of paste, mortar and concrete. It provides the current development of application of nano-silica in paste, mortar and concrete. Finally, the future trend/potential and implication of nano-silica in cement-based materials is discussed

1 January 2018 in Nanotheranostics
Verified
Journal Article
Open access
SOSonali
Sonali
MVMatte Kasi Viswanadh
Matte Kasi Viswanadh
Rahul Pratap SinghRahul Pratap Singh
Rahul Pratap Singh
PAPoornima Agrawal
Poornima Agrawal
Abhishesh Kumar MehataAbhishesh Kumar Mehata
Abhishesh Kumar Mehata
Muthu M.S.Muthu M.S.
Muthu M.S.
Nanotheranostics have demonstrated the development of advanced platforms that can diagnose brain cancer at early stages, initiate first-line therapy, monitor it, and if needed, rapidly start subsequent treatments. In brain nanotheranostics, therapeutic as well as diagnostic entities are loaded in a single nanoplatform, which can be further developed as a clinical formulation for targeting various modes of brain cancer. In the present review, we concerned about theranostic nanosystems established till now in the research field. These include gold nanoparticles, carbon nanotubes, magnetic nanoparticles, mesoporous silica nanoparticles, quantum dots, polymeric nanoparticles, upconversion nanoparticles, polymeric micelles, solid lipid nanoparticles and dendrimers for the advanced detection and treatment of brain cancer with advanced features. Also, we included the role of three-dimensional models of the BBB and cancer stem cell concept for the advanced characterization of nanotheranostic systems for the unification of diagnosis and treatment of brain cancer. In future, brain nanotheranostics will be able to provide personalized treatment which can make brain cancer even remediable or at least treatable at the primary stages.

31 March 2016 in Drug Delivery
Verified
Journal Article
Closed access
PDF file
SOSonali
Sonali
Rahul Pratap SinghRahul Pratap Singh
Rahul Pratap Singh
NSNitesh Singh
Nitesh Singh
GSGunjan Sharma
Gunjan Sharma
MVMahalingam R. Vijayakumar
Mahalingam R. Vijayakumar
SSSonali Sonali
Sonali Sonali
Diagnosis and therapy of brain cancer was often limited due to low permeability of delivery materials across the blood−brain barrier (BBB) and their poor penetration into the brain tissue. This study explored the possibility of utilizing theranostic D-alpha-tocopheryl polyethylene glycol 1000 succinate mono-ester (TPGS) liposomes as nanocarriers for minimally invasive brain targeted imaging and therapy (brain theranostics). The aim of this work was to formulate transferrin conjugated TPGS coated theranostic liposomes, which contain both docetaxel and quantum dots (QDs) for imaging and therapy of brain cancer. The theranostic liposomes with and without transferrin decoration were prepared and characterized for their particle size, polydispersity, morphology, drug encapsulation efficiency, in-vitro release study and brain theranostics. The particle sizes of the non-targeted and targeted theranostic liposomes were found below 200 nm. Nearly, 70% of drug encapsulation efficiency was achieved with liposomes. The drug release from transferrin conjugated theranostic liposomes was sustained for more than 72 h with 70% of drug release. The in-vivo results indicated that transferrin receptor targeted theranostic liposomes could be a promising carrier for brain theranostics due to nano-sized delivery and its permeability which provided an improved and prolonged brain targeting of docetaxel and QDs in comparison to the non-targeted preparations.

22 August 2014 in Drug Delivery
Verified
Journal Article
Closed access
PDF file
SOSonali
Sonali
PAPoornima Agrawal
Poornima Agrawal
Rahul Pratap SinghRahul Pratap Singh
Rahul Pratap Singh
CRChellappa V. Rajesh
Chellappa V. Rajesh
SSSanjay Singh
Sanjay Singh
MMMadaswamy Sona Muthu
Madaswamy Sona Muthu
Transferrin receptor-targeted vitamin E TPGS micelles for brain cancer therapy: preparation, characterization and brain distribution in rats. . ???aop.label???. doi: 10.3109/10717544.2015.1094681

1 November 2016 in Colloids and Surfaces B: Biointerfaces
Verified
Journal Article
Closed access
SOSonali
Sonali
Rahul Pratap SinghRahul Pratap Singh
Rahul Pratap Singh
GSGunjan Sharma
Gunjan Sharma
LKLakshmi Kumari
Lakshmi Kumari
BKBiplob Koch
Biplob Koch
MMMadaswamy S. Muthu
Madaswamy S. Muthu

1 May 2017 in Materials Science and Engineering: C
Verified
Journal Article
Closed access
PAPoornima Agrawal
Poornima Agrawal
Rahul Pratap SinghRahul Pratap Singh
Rahul Pratap Singh
SOSonali
Sonali
LKLaksmi Kumari
Laksmi Kumari
GSGunjan Sharma
Gunjan Sharma
MMMadaswamy S. Muthu
Madaswamy S. Muthu